Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
brentuximab vedotin
2
×
clinical trials
fda
life sciences
national blog main
national top stories
seattle
seattle blog main
seattle genetics
seattle top stories
andrew berens
antibody drug conjugate (adc)
astrazeneca
breast cancer
cancer drugs
capecitabine
clay siegall
daiichi sankyo
deals
enfortumab vedotin
gilead sciences
glaxosmithkline
immunomedics
ladiratuzumab vedotin
lymphoma
macrogenics
merck
new york blog main
new york top stories
pembrolizumab
puma biotechnology
sacituzumab govitecan
svb leerink
takeda pharmaceutical
targeted therapy
trastuzumab
trastuzumab deruxtecan
tucatinib
What
cancer
2
×
drug
genetics
seattle
2
×
billion
breast
clinical
company
deals
development
experimental
fda
goals
headed
hits
key
lands
line
main
merck
met
nod
pair
pivotal
receive
reported
review
seagen
seek
study
that’s
trial
Language
unset
Current search:
cancer
×
biotech
×
seattle
×
" brentuximab vedotin "
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}